GLEESON, M. ET al.: “Daily Probiotic’s (Lactobacillus casei Shirota) Reduction of Infection Incidence in Athletes.” In: Int J Sport Nutr Exerc Metab. 2011 February; 21 (1): pp. 55–64.
GOLDIN, B.R.; GORBACH, S.L.: “Clinical Indications for Probiotics: An Overview.” In: Clinical Infectious Diseases. 2008; 46 (Suppl. 2): pp. S96–S100.
GORKIEWICZ, G.: “CONTRIBUTIONS of the Physiological Gut Microflora to Health and Disease.” In: J Gastroenterol Hepatol Erkr. 2009; 7 (1): pp. 15–18.
GREWE, K.: Prävalenz von Salmonella spp. in der primären Geflügelproduktion und Broilerschlachtung—Salmonelleneintrag bei Schlachtgeflügel während des Schlachtprozesses [Prevalence of Salmonella spp. in Primary Poultry Production and the Slaughter of Broiler Chickens—Salmonella Contamination of Slaughter Poultry during the Slaughtering Process]. Hanover: Hanover University of Veterinary Medicine, 2011. (In German)
GUSEO. A.: “THE Parkinson Puzzle.” In: Orv Hetil. 2012 December 30; 153 (52): pp. 2060–2069.
HERBARTH, O. ET al.: “Helicobacter pylori Colonisation and Eczema.” In: Journal of Epidemiology and Community Health. 2007; 61 (7): pp. 638–640.
HULLAR, M.A.; LAMPE, J.W.: “The Gut Microbiome and Obesity.” In: Nestle Nutr Inst Workshop Ser. 2012; 73: pp. 67–79.
JERNBERG, C. ET al.: “Long-Term Impacts of Antibiotic Exposure on the Human Intestinal Microbiota.” In: Microbiology. 2010 November; 156 (Pt. 11): pp. 3216–3223.
JIN, C.; FLAVELL, R.A.: “Innate Sensors of Pathogen and Stress: Linking Inflammation to Obesity.” In: J Allergy Clin Immunol. 2013 August; 132 (2): pp. 287–294.
JIRILLO, E. ET al.: “Heathy Effects Exerted by Prebiotics, Probiotics, and Symbiotics with Special Reference to Their Impact on the Immune System.” In: Int J Vitam Nutr Res. 2012 June; 82 (3): pp. 200–208.
JONES, M.L. ET al.: “Cholesterol-Lowering Efficacy of a Microencapsulated Bile Salt Hydrolase-Active Lactobacillus reuteri NIMB 30242 Yoghurt Formulation in Hypercholesterolaemic Adults.” In: British Journal of Nutrition. 2012; 107 (10): pp. 1505–1513.
JUMPERTZ, R. ET al.: “Energy-Balance Studies Reveal Associations between Gut Microbes, Caloric Load, and Nutrient Absorption in Humans.” In: Am J Clin Nutr. 2011; 94 (1): pp. 58–65.
KATZ, S.E.: The Art of Fermentation: An In-Depth Exploration of Essential Concepts and Processes from around the World. Chelsea: Chelsea Green Publishing, 2012.
KOUNTOURAS, J. ET al.: “Helicobacter pylori Infection and Parkinson’s Disease: Apoptosis as an Underlying Common Contributor.” In: Eur J Neurol. 2012 June; 19 (6): p. e56.
KRZNARICA, Z. ET al.: “Gut Microbiota and Obesity.” In: Dig Dis. 2012; 30: p. 196–200.
KUMAR, M. et al.: “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases.” In: Exp Diabetes Res. 2012; 2012: 902917.
MACFARLANE, G.T. ET al.: “Bacterial Metabolism and Health-Related Effects of Galactooligosaccharides and Other Prebiotics.” In: J Appl Microbiol. 2008 February; 104 (2): pp. 305–344.
MANN, G.V. ET al.: “Atherosclerosis in the Masai.” In: Am J Epidemiol. 1972; 95 (1): pp. 26–37.
MARSHALL, B. J.: “Unidentified Curved Bacillus on Gastric Epithelium in Active Chronic Gastritis.” In: Lancet. 1983 June 4; 1 (8336): pp. 1273 ff.
MARTINSON, V.G. ET al.: “A Simple and Distinctive Microbiota Associated with Honey Bees and Bumble Bees.” In: Mol Ecol. 2011 February; 20 (3): pp. 619–628.
MATAMOROS, S. ET al.: “Development of Intestinal Microbiota in Infants and Its Impact on Health.” In: Trends Microbiol. 2013 April; 21 (4): pp. 167–173.
MOODLEY, Y. ET al.: “The Peopling of the Pacific from a Bacterial Perspective.” In: Science. 2009 January 23; 323 (5913): pp. 527–530.
MORI, K. ET al.: “Does the Gut Microbiota Trigger Hashimoto’s Thyroiditis?” In: Discov Med. 2012 November; 14 (78): pp. 321–326.
MUSSO, G. ET al.: “Gut Microbiota as a Regulator of Energy Homeostasis and Ectopic Fat Deposition: Mechanisms and Implications for Metabolic Disorders.” In: Current Opinion in Lipidology. 2010; 21 (1): pp. 76–83.
NAGPAL, R. ET al.: “Probiotics, Their Health Benefits and Applications for Developing Healthier Foods: A Review.” In: FEMS Microbiol Lett. 2012 September; 334 (1): pp. 1–15.
NAKAMURA, Y.K.; OMAYE, S.T.: “Metabolic Diseases and Pro- and Prebiotics: Mechanistic Insights.” In: Nutr Metab (Lond). 2012 June 19; 9 (1): p. 60.
NICOLA, J.P. ET al.: “Functional Toll-Like Receptor 4 Conferring Lipopolysaccharide Responsiveness Is Expressed in Thyroid Cells.” In: Endocrinology. 2009 January; 150 (1): pp. 500–508.
NIELSEN, H.H. ET al.: “Treatment for Helicobacter pylori Infection and Risk of Parkinson’s Disease in Denmark.” In: Eur J Neurol. 2012 June; 19 (6): pp. 864–869.
NORRIS, V. ET al.: “Bacteria Control Host Appetites.” In: J Bacteriol. 2013 February; 195 (3): pp. 411–416.
OKUSAGA, O.; POSTOLACHE, T.T.: “Toxoplasma gondii, the Immune System, and Suicidal Behavior.” In: Dwivedi. Y. (Ed.): The Neurological Basis of Suicide. Boca Raton, Florida: CRC Press, 2012: pp. 159–194.
OTTMAN, N. ET al.: “The Function of Our Microbiota: Who Is Out There and What Do They Do?” In: Front Cell Infect Microbiol. 2012 August 9; 2: p. 104.
PAVLOVÍC, N. ET al.: “Probiotics-Interactions with Bile Acids and Impact on Cholesterol Metabolism.” In: Appl Biochem Biotechnol. 2012; 168: pp. 1880–1895.
PETROF, E.O. ET al.: “Stool Substitute Transplant Therapy for the Eradications of Clostridium difficile Infection ‘RePOOPulating’ the Gut.” In: Microbiome. 2013 January 9; 1 (1): p. 3.
READING, N.C.; KASPER, D.L.: “The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis.” In: Front Microbiol. 2011 July 7; 2: p. 148.
ROBERFROID, M. ET al.: “Prebiotic Effects: Metabolic and Health Benefits.” In: Br J Nutr. 2010 August; 104 (Suppl. 2): pp. S1–S63.
SANDERS, M.E. ET al.: “An Update on the Use and Investigation of Probiotics in Health and Disease.” In: Gut. 2013; 62 (5): pp. 787–796.
SANZA, Y. et al.: “Understanding the Role of Gut Microbes and Probiotics in Obesity: How Far Are We?” In: Pharmacol Res. 2013 March; 69 (1): pp. 144–155.
SCHMIDT, C.: “THE Startup Bugs.” In: Nat Biotechnol. 2013 April; 31 (4): pp. 279–281.
SCHOLZ-AHRENS, K.E. ET al.: “Prebiotics, Probiotics, and Synbiotics Affect Mineral Absorption, Bone Mineral Content, and Bone Structure.” In: J Nutr. 2007 March; 137 (3 Suppl. 2): pp. 838S–846S.
SCHWARZ, S. ET al.: “Horizontal versus Familial Transmission of Helicobacter pylori.” In: PLoS Pathog. 2008 October; 4 (10): p. e1000180.
SHEN, J. ET al.: “The Gut Microbiota, Obesity and Insulin Resistance.” In: Mol Aspects Med. 2013 February; 34 (1): pp. 39–58.
STARKENMANN, C. ET al.: “Olfactory Perception of Cysteine-S–Conjugates from Fruits and Vegetables.” In: J Agric Food Chem. 2008 October 22; 56 (20): pp. 9575–9580.
STOWELL, S.R.: “INNATE Immune Lectins Kill Bacteria Expressing Blood Group Antigen.” In: Nat Med. 2010 March; 16 (3): pp. 295–301.
TÄNGDÉN, T. ET al.: “Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M–Type Extended-Spectrum ß-Lactamases: A Prospective Study with Swedish Volunteers.” In: Antimicrob Agents Chemother. 2010 September; 54 (9): pp. 3564–3568.
TEIXEIRA, T.F.: “POTENTIAL Mechanisms for the Emerging Link between Obesity and Increased Intestinal Permeability.” In: Nutr Res. 2012 September; 32 (9): pp. 637–647.
TORREY, E.F. ET al.: “Antibodies to Toxoplasma gondii in Patients with Schizophrenia: A Meta-Analysis.” In: Schizophr Bull. 2007 May; 33 (3): pp. 729–736.
TREMAROLI, V.; BÄCKHED, F.: “Functional Interactions between the Gut Microbiota and Host Metabolism.” In: Nature. 2012 September 13; 489 (7415): pp. 242–249.
TURNBAUGH, P.J.; GORDON, J.L.: “The Core Gut Microbiome, Energy Balance and Obesity.” In: J Physiol. 2009; 587 (17): pp. 4153–4158.
DE VRE
SE, M.; Schrezenmeir, J.: “Probiotics, Prebiotics, and Synbtiotics.” In: Adv Biochem Engin/Biotechnol. 2008; 111: pp. 1–66.
DE VRIESE, J.: “Medical Research. The Promise of Poop.” In: Science. 2013 August 30; 341 (6149): pp. 954–957.
VYAS, U.; RANGANATHAN, N.: “Probiotics, Prebiotics and Synbiotics: Gut and Beyond.” In: Gastroenterol Res Pract. 2012; 2012: 872716.
WEBSTER, J.P. ET al.: “Effect of Toxoplasma gondii upon Neophobic Behaviour in Wild Brown Rats, Rattus norvegicus.” In: Parasitology. 1994 July; 109 (pt. 1): pp. 37–43.
WICHMANN-SCHAUER, H.: Verbrauchertipps: Schutz vor Lebensmittelin-fektionen im Privathaushalt [Tips: Protection against Food Infections in Private Households]. Berlin: German Federal Institute for Risk Assessment, 2007. (In German)
WU, G.D. ET al.: “Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes.” In: Science. 2011 October 7; 334 (6052): pp. 105–108.
YATSUNENKO, T. et al.: “Human Gut Microbiome Viewed across Age and Geography.” In: Nature. 2012 May 9; 486 (7402): pp. 222–227.
ZIPRIS, D.: “THE Interplay between the Gut Microbiota and the Immune System in the Mechanism of Type 1 Diabetes.” In: Curr Opin Endocrinol Diabetes Obes. 2013 August; 20 (4): pp. 265–270.
Part Four
AKKASHEH, G. ET al.: “Clinical and Metabolic Response to Probiotic Administration in Patients with Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.” In: Nutrition. 2016; 32: pp. 315–320.
ALLEN, A.P. ET al.: “Bifidobacterium longum 1714 as a Translational Psychobiotic: Modulation of Stress, Electrophysiology and Neurocognition in Healthy Volunteers.” In: Transl Psychiatry. 2016; 6, e939; doi:10.1038/tp.2016.191.
BENTON, D. ET al.: “Impact of Consuming a Milk Drink Containing a Probiotic on Mood and Cognition.” In: Eur J Clin Nutr. 2007; 61: pp. 355–361.
DIOP, L. ET al.: “Probiotic Food Supplement Reduces Stress-Induced Gastrointestinal Symptoms in Volunteers: A Double-Blind, Placebo-Controlled, Randomized Trial.” In: Nutrition Research. 2008; 28: p. 1.
KATO-KATAOKA, A. ET al.: “Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress.” In: Appl Environ Microbiol. 2016; 82: pp. 3649–3658.
KELLY, J.R. ET al.: “Transferring the Blues: Depression-Associated Gut Microbiota Induces Neurobehavioural Changes in the Rat.” In: Psychiatr. Res. 2016; 82: pp. 109–118.
KRUIJT, A.W. ET al.: “Cognitive Reactivity, Implicit Associations, and the Incidence of Depression: a Two-Year Prospective Study.” In: PLoS One. 2013; 8 (7), e70245.
MCKEAN, J. ET al.: “Probiotics and Subclinical Psychological Symptoms in Healthy Participants: A Systematic Review and Meta-Analysis.” In: J. Altern Complement Med. 2017 April; 23 (4): pp. 249–258. doi: 10.1089/acm.2016.0023. Epub 2016 November 14.
MESSAOUDI, M. ET al.: “Beneficial Psychological Effects of a Probiotic Formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in Healthy Human Volunteers.” In: Gut Microbes. 2011 July-August; 2 (4): pp. 256–261. doi: 10.4161/gmic.2.4.16108. Epub 2011 July 1.
ROMIJN, A.R. ET al.: “Double-Blind, Randomized, Placebo-Controlled Trial of Lactobacillus helveticus and Bifidobacterium longum for the Symptoms of Depression.” In: Australian & New Zealand Journal of Psychiatry. 2017 August; 51 (8): pp. 810–821. doi: 10.1177/0004867416686694. Epub 2017 January 10.
SARKAR, A. ET al.: “Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals.” In: Trends Neurosci. 2016 November; 39 (11): pp. 763–781.
STEENBERGEN, L. ET al.: “A Randomized Controlled Trial to Test the Effect of Multispecies Probiotics on Cognitive Reactivity to Sad Mood.” In: Brain, Behavior, and Immunity. 2015 August; 48: pp. 258–264.
About the Author
GIULIA ENDERS, MD, is a resident doctor for Internal Medicine and Gastroenterology and a two-time scholarship winner of the Wilhelm and Else Heraeus Foundation. She lives in Mannheim and Frankfurt, Germany.
About the Illustrator
JILL ENDERS is a graphic designer whose main focus is communication in science. She received a scholarship from the Heinrich Hertz Society for her work. In 2013, she founded a collaborative network of designers and scientists.
Copyright © 2015, 2018 by Giulia Enders
Illustrations copyright © 2015, 2018 by Jill Enders
Translation copyright © 2015, 2018 by David Shaw
Originally published in Germany as Darm mit Charme by Ullstein 2014
First published in English by Scribe 2015
All rights reserved. No part of this book may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, without the prior written consent of the publisher or a license from The Canadian
Copyright Licensing Agency (Access Copyright). For a copyright license, visit
www.accesscopyright.ca or call toll free to 1-800-893-5777.
Greystone Books Ltd.
greystonebooks.com
Cataloguing data available from Library and Archives Canada
ISBN 978-1-77164-376-4 pbk.
ISBN 978-1-77164-378-8 epub
Editing by Jane Billinghurst
Cover and interior illustrations by Jill Enders
Cover and interior design by Peter Cocking and Nayeli Jimenez
We gratefully acknowledge the support of the Canada Council for the Arts, the British Columbia Arts Council, the Province of British Columbia through the Book Publishing Tax Credit, and the Government of Canada for our publishing activities.
The advice provided in this book has been carefully considered and checked by the author and publisher. It should not, however, be regarded as a substitute for competent medical advice. Therefore, all information in this book is provided without any warranty or guarantee on the part of the publisher or the author. Neither the author nor the publisher or their representatives shall bear any
Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition) Page 24
